Sale!

CLDN19 Gene Hypomagnesemia Type 5 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CLDN19 Gene Hypomagnesemia Type 5 NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the CLDN19 gene responsible for familial hypomagnesemia with hypercalciuria and nephrocalcinosis. This specialized test uses next-generation sequencing technology to detect genetic variations that cause severe magnesium deficiency, kidney dysfunction, and vision problems. Individuals with unexplained low magnesium levels, recurrent kidney stones, or family history of kidney disorders should consider this test. Early detection enables proactive management to prevent progressive kidney damage and vision impairment. The test costs $500 USD and provides results within 3-4 weeks using blood or DNA samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CLDN19 Gene Hypomagnesemia Type 5 NGS Genetic DNA Test

Comprehensive Genetic Testing for Kidney Magnesium Disorders

The CLDN19 Gene Hypomagnesemia Type 5 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for inherited kidney disorders. This advanced test specifically targets mutations in the CLDN19 gene, which plays a crucial role in maintaining proper magnesium balance and kidney function. Hypomagnesemia type 5, also known as familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), is a rare autosomal recessive disorder that can lead to severe kidney complications if left undiagnosed.

What Does This Test Measure?

This comprehensive genetic analysis utilizes next-generation sequencing (NGS) technology to examine the complete coding region of the CLDN19 gene. The test specifically detects:

  • Point mutations, deletions, and insertions in the CLDN19 gene
  • Genetic variations affecting claudin-19 protein function
  • Mutations responsible for impaired renal magnesium reabsorption
  • Genetic markers associated with progressive kidney damage
  • Inheritance patterns for family planning purposes

Who Should Consider This Test?

This genetic test is particularly important for individuals experiencing:

  • Unexplained persistent hypomagnesemia (low magnesium levels)
  • Recurrent kidney stones or nephrocalcinosis
  • Family history of kidney disorders or magnesium deficiency
  • Vision problems including severe myopia or macular coloboma
  • Children with failure to thrive and developmental delays
  • Individuals with elevated calcium levels in urine (hypercalciuria)
  • Patients with progressive kidney dysfunction of unknown cause

Clinical Benefits of Testing

Early genetic diagnosis through CLDN19 testing provides numerous clinical advantages:

  • Early Intervention: Enables proactive management before irreversible kidney damage occurs
  • Personalized Treatment: Guides targeted magnesium supplementation and dietary modifications
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Disease Monitoring: Establishes baseline for ongoing kidney function surveillance
  • Vision Care: Facilitates early ophthalmological interventions for associated eye conditions
  • Preventive Care: Helps prevent complications like end-stage renal disease

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and physicians:

  • Positive Result: Indicates the presence of CLDN19 gene mutations, confirming diagnosis of hypomagnesemia type 5
  • Negative Result: Suggests absence of detectable CLDN19 mutations, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further evaluation
  • Carrier Status: Determines if you carry one copy of the mutated gene without showing symptoms

Test Details and Pricing

Test Feature Details
Test Name CLDN19 Gene Hypomagnesemia Type 5 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS)

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of potential implications with healthcare provider
  • Understanding of insurance coverage and out-of-pocket costs

Nationwide Testing Availability

GGC DNA provides comprehensive genetic testing services across the United States. We have conveniently located branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art laboratories ensure accurate and reliable results regardless of your location.

Take Control of Your Health Today

Don’t let uncertainty about genetic kidney disorders affect your quality of life. Early detection through CLDN19 genetic testing can provide the answers you need to make informed healthcare decisions and implement effective management strategies. Our team of genetic specialists is ready to guide you through the testing process and help interpret your results.

Ready to schedule your test? Call us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and protecting your kidney function for years to come.